SAGA Diagnostics is a medical laboratory located in Lund that specializes in the early detection of molecular residual disease (MRD). The laboratory focuses on intercepting cancer at its most treatable stages by utilizing patient-specific and tumor-informed approaches. This methodology aims to empower treatment decisions by providing enhanced insights into the patient's condition.
The laboratory is known for its high sensitivity and specificity in detection, which contributes to its commitment to advancing cancer monitoring and treatment. SAGA Diagnostics offers timely results, typically within a month, and is actively engaged in ongoing research and innovation in the field of diagnostics. The organization's goal is to improve patient outcomes through precise monitoring and to redefine cancer care using advanced scientific techniques.